We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Apogenix Receives €3 Million Grant for the Development of a Companion Diagnostic Test

News   Feb 27, 2016

 
Apogenix Receives €3 Million Grant for the Development of a Companion Diagnostic Test
 
 
 

RELATED ARTICLES

AI-Capnograph Distinguishes Between Emphysema and Heart Failure

News

By analyzing carbon dioxide in the breath, an algorithm could help determine how to treat patients.

READ MORE

Machine-learning System Could Aid Critical Decisions in Sepsis Care

News

This predictive model could guide clinicians in deciding when to give potentially life-saving drugs to patients being treated for sepsis in the emergency room.

READ MORE

Sequencing Offers New Hope for Rare Cancers

News

A cancer’s genetic sequence may be the key to matching people with rare cancers to the right anti-cancer treatments, according to a new clinical trial instigated by patients.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE